Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

An immortalised mesenchymal stem cell line maintains mechano-responsive behaviour and can be used as a reporter of substrate stiffness.

Galarza Torre A, Shaw JE, Wood A, Gilbert HTJ, Dobre O, Genever P, Brennan K, Richardson SM, Swift J.

Sci Rep. 2018 Jun 12;8(1):8981. doi: 10.1038/s41598-018-27346-9.

2.

How cell culture conditions affect the microstructure and nanomechanical properties of extracellular matrix formed by immortalized human mesenchymal stem cells: An experimental and modelling study.

Duan P, Toumpaniari R, Partridge S, Birch MA, Genever PG, Bull SJ, Dalgarno KW, McCaskie AW, Chen J.

Mater Sci Eng C Mater Biol Appl. 2018 Aug 1;89:149-159. doi: 10.1016/j.msec.2018.03.027. Epub 2018 Mar 27.

PMID:
29752083
3.

Glycans modify mesenchymal stem cell differentiation to impact on the function of resulting osteoblasts.

Wilson KM, Jagger AM, Walker M, Seinkmane E, Fox JM, Kröger R, Genever P, Ungar D.

J Cell Sci. 2018 Feb 14;131(4). pii: jcs209452. doi: 10.1242/jcs.209452.

4.

One Filter, One Sample, and the N- and O-Glyco(proteo)me: Toward a System to Study Disorders of Protein Glycosylation.

Skeene K, Walker M, Clarke G, Bergström E, Genever P, Ungar D, Thomas-Oates J.

Anal Chem. 2017 Jun 6;89(11):5840-5849. doi: 10.1021/acs.analchem.7b00143. Epub 2017 May 10.

5.

Real-Time Analysis of Endogenous Wnt Signalling in 3D Mesenchymal Stromal Cells.

Saleh F, Carstairs A, Etheridge SL, Genever P.

Stem Cells Int. 2016;2016:7132529. doi: 10.1155/2016/7132529. Epub 2016 Sep 7.

6.

Glycan Profiling Shows Unvaried N-Glycomes in MSC Clones with Distinct Differentiation Potentials.

Wilson KM, Thomas-Oates JE, Genever PG, Ungar D.

Front Cell Dev Biol. 2016 May 31;4:52. doi: 10.3389/fcell.2016.00052. eCollection 2016.

7.

Correction to Collagen-Poly(N-isopropylacrylamide) Hydrogels with Tunable Properties.

Barnes AL, Genever PG, Rimmer S, Coles MC.

Biomacromolecules. 2016 Jun 13;17(6):2309. doi: 10.1021/acs.biomac.6b00645. Epub 2016 May 23. No abstract available.

PMID:
27214304
8.

Collagen-Poly(N-isopropylacrylamide) Hydrogels with Tunable Properties.

Barnes AL, Genever PG, Rimmer S, Coles MC.

Biomacromolecules. 2016 Mar 14;17(3):723-34. doi: 10.1021/acs.biomac.5b01251. Epub 2016 Feb 5. Erratum in: Biomacromolecules. 2016 Jun 13;17(6):2309.

PMID:
26686360
9.

lin28 proteins promote expression of 17∼92 family miRNAs during amphibian development.

Warrander F, Faas L, Kovalevskiy O, Peters D, Coles M, Antson AA, Genever P, Isaacs HV.

Dev Dyn. 2016 Jan;245(1):34-46. doi: 10.1002/dvdy.24358. Epub 2015 Nov 14.

10.

Human cell dedifferentiation in mesenchymal condensates through controlled autophagy.

Pennock R, Bray E, Pryor P, James S, McKeegan P, Sturmey R, Genever P.

Sci Rep. 2015 Aug 20;5:13113. doi: 10.1038/srep13113.

11.

A virtual approach to evaluate therapies for management of multiple myeloma induced bone disease.

Ji B, Genever PG, Fagan MJ.

Int J Numer Method Biomed Eng. 2016 Mar;32(3):e02735. doi: 10.1002/cnm.2735. Epub 2015 Sep 2.

12.

Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes.

James S, Fox J, Afsari F, Lee J, Clough S, Knight C, Ashmore J, Ashton P, Preham O, Hoogduijn M, Ponzoni Rde A, Hancock Y, Coles M, Genever P.

Stem Cell Reports. 2015 Jun 9;4(6):1004-15. doi: 10.1016/j.stemcr.2015.05.005.

13.

In vivo biocompatibility of custom-fabricated apatite-wollastonite-mesenchymal stromal cell constructs.

Lee JA, Knight CA, Kun X, Yang XB, Wood DJ, Dalgarno KW, Genever PG.

J Biomed Mater Res A. 2015 Oct;103(10):3188-200. doi: 10.1002/jbm.a.35448. Epub 2015 Mar 30.

PMID:
25777813
14.

A predator-prey based mathematical model of the bone remodelling cycle: exploring the relationship between the model parameters and biochemical factors.

Ji B, Yang Q, Genever PG, Patton RJ, Fagan MJ.

Proc Inst Mech Eng H. 2014 Oct;228(10):1035-42. doi: 10.1177/0954411914554633. Epub 2014 Oct 14.

PMID:
25316684
15.

Investigating the efficacy of bisphosphonates treatment against multiple myeloma induced bone disease using a computational model.

Ji B, Yang Q, Genever PG, Fagan MJ.

Biomed Mater Eng. 2014;24(6):3373-8. doi: 10.3233/BME-141160.

PMID:
25227047
16.

Mathematical modelling of the pathogenesis of multiple myeloma-induced bone disease.

Ji B, Genever PG, Patton RJ, Fagan MJ.

Int J Numer Method Biomed Eng. 2014 Nov;30(11):1085-102. doi: 10.1002/cnm.2645. Epub 2014 May 9.

17.

Human Allogeneic Bone Marrow and Adipose Tissue Derived Mesenchymal Stromal Cells Induce CD8+ Cytotoxic T Cell Reactivity.

Roemeling-van Rhijn M, Reinders ME, Franquesa M, Engela AU, Korevaar SS, Roelofs H, Genever PG, Ijzermans JN, Betjes MG, Baan CC, Weimar W, Hoogduijn MJ.

J Stem Cell Res Ther. 2013 Dec 12;3(Suppl 6):004.

18.

Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive In vitro and in a Humanized Allograft Rejection Model.

Roemeling-van Rhijn M, Khairoun M, Korevaar SS, Lievers E, Leuning DG, Ijzermans JN, Betjes MG, Genever PG, van Kooten C, de Fijter HJ, Rabelink TJ, Baan CC, Weimar W, Roelofs H, Hoogduijn MJ, Reinders ME.

J Stem Cell Res Ther. 2013 Nov 25;Suppl 6(1):20780.

19.

miRNA-221 and miRNA-222 synergistically function to promote vascular calcification.

Mackenzie NC, Staines KA, Zhu D, Genever P, Macrae VE.

Cell Biochem Funct. 2014 Mar;32(2):209-16. doi: 10.1002/cbf.3005. Epub 2013 Oct 8.

20.

Stem cell treatment for musculoskeletal disease.

Carstairs A, Genever P.

Curr Opin Pharmacol. 2014 Jun;16:1-6. doi: 10.1016/j.coph.2014.01.005. Epub 2014 Feb 19. Review.

PMID:
24561638
21.

Wnt-dependent osteogenic commitment of bone marrow stromal cells using a novel GSK3β inhibitor.

Cook DA, Fellgett SW, Pownall ME, O'Shea PJ, Genever PG.

Stem Cell Res. 2014 Mar;12(2):415-27. doi: 10.1016/j.scr.2013.10.002. Epub 2013 Oct 16.

22.

Regulation of mesenchymal stem cell differentiation.

Cook D, Genever P.

Adv Exp Med Biol. 2013;786:213-29. doi: 10.1007/978-94-007-6621-1_12. Review.

PMID:
23696359
23.

Lin28 proteins are required for germ layer specification in Xenopus.

Faas L, Warrander FC, Maguire R, Ramsbottom SA, Quinn D, Genever P, Isaacs HV.

Development. 2013 Mar;140(5):976-86. doi: 10.1242/dev.089797. Epub 2013 Jan 23.

24.

The effect of osteocyte apoptosis on signalling in the osteocyte and bone lining cell network: a computer simulation.

Jahani M, Genever PG, Patton RJ, Ahwal F, Fagan MJ.

J Biomech. 2012 Nov 15;45(16):2876-83. doi: 10.1016/j.jbiomech.2012.08.005. Epub 2012 Oct 3.

PMID:
23040883
25.

Analysis of human mesenchymal stem cells on a cross-linked collagen-based surgical implant material.

Arca T, Proffitt J, Genever P.

Biomed Mater Eng. 2012;22(5):261-76. doi: 10.3233/BME-2012-0716.

PMID:
23023143
26.

Three-dimensional in vitro culture techniques for mesenchymal stem cells.

Saleh FA, Frith JE, Lee JA, Genever PG.

Methods Mol Biol. 2012;916:31-45. doi: 10.1007/978-1-61779-980-8_4.

PMID:
22914931
27.

A novel mathematical model of bone remodelling cycles for trabecular bone at the cellular level.

Ji B, Genever PG, Patton RJ, Putra D, Fagan MJ.

Biomech Model Mechanobiol. 2012 Sep;11(7):973-82. doi: 10.1007/s10237-011-0366-3. Epub 2012 Jan 5.

PMID:
22218996
28.

Effects of endothelial cells on human mesenchymal stem cell activity in a three-dimensional in vitro model.

Saleh FA, Whyte M, Genever PG.

Eur Cell Mater. 2011 Oct 19;22:242-57; discussion 257.

29.

Turning round: multipotent stromal cells, a three-dimensional revolution?

Saleh FA, Genever PG.

Cytotherapy. 2011 Sep;13(8):903-12. doi: 10.3109/14653249.2011.586998. Epub 2011 Jun 22. Review.

PMID:
21696237
30.

Prospects of stem cell therapy in osteoarthritis.

Roberts S, Genever P, McCaskie A, De Bari C.

Regen Med. 2011 May;6(3):351-66. doi: 10.2217/rme.11.21.

31.

The generation of three-dimensional tissue structures with mesenchymal stem cells.

Genever PG.

Altern Lab Anim. 2010 Dec;38 Suppl 1:31-4.

PMID:
21404721
32.

Generating 3D tissue constructs with mesenchymal stem cells and a cancellous bone graft for orthopaedic applications.

Arca T, Proffitt J, Genever P.

Biomed Mater. 2011 Apr;6(2):025006. doi: 10.1088/1748-6041/6/2/025006. Epub 2011 Feb 28.

PMID:
21358028
33.

Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT).

Hoogduijn MJ, Popp FC, Grohnert A, Crop MJ, van Rhijn M, Rowshani AT, Eggenhofer E, Renner P, Reinders ME, Rabelink TJ, van der Laan LJ, Dor FJ, Ijzermans JN, Genever PG, Lange C, Durrbach A, Houtgraaf JH, Christ B, Seifert M, Shagidulin M, Donckier V, Deans R, Ringden O, Perico N, Remuzzi G, Bartholomew A, Schlitt HJ, Weimar W, Baan CC, Dahlke MH; MISOT Study Group.

Transplantation. 2010 Jul 27;90(2):124-6. doi: 10.1097/TP.0b013e3181ea4240.

PMID:
20606604
34.

SOX9 determines RUNX2 transactivity by directing intracellular degradation.

Cheng A, Genever PG.

J Bone Miner Res. 2010 Dec;25(12):2680-9. doi: 10.1002/jbmr.174. Epub 2010 Jun 30. Erratum in: J Bone Miner Res. 2011 Feb;26(2):439.

35.

Regulation of mesenchymal stem cell activity by endothelial cells.

Saleh FA, Whyte M, Ashton P, Genever PG.

Stem Cells Dev. 2011 Mar;20(3):391-403. doi: 10.1089/scd.2010.0168. Epub 2010 Oct 17.

PMID:
20536359
36.

SNARE-dependent glutamate release in megakaryocytes.

Thompson CJ, Schilling T, Howard MR, Genever PG.

Exp Hematol. 2010 Jun;38(6):504-15. doi: 10.1016/j.exphem.2010.03.011. Epub 2010 Mar 27.

37.

Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential.

Frith JE, Thomson B, Genever PG.

Tissue Eng Part C Methods. 2010 Aug;16(4):735-49. doi: 10.1089/ten.TEC.2009.0432.

PMID:
19811095
38.

Gamma-secretase-dependent cleavage of amyloid precursor protein regulates osteoblast behavior.

McLeod J, Curtis N, Lewis HD, Good MA, Fagan MJ, Genever PG.

FASEB J. 2009 Sep;23(9):2942-55. doi: 10.1096/fj.08-121657. Epub 2009 Apr 17.

PMID:
19376818
39.

Functional nicotinic and muscarinic receptors on mesenchymal stem cells.

Hoogduijn MJ, Cheng A, Genever PG.

Stem Cells Dev. 2009 Jan-Feb;18(1):103-12. doi: 10.1089/scd.2008.0032.

PMID:
18393628
40.

Transcriptional control of mesenchymal stem cell differentiation.

Frith J, Genever P.

Transfus Med Hemother. 2008 Jun;35(3):216-27. doi: 000127448. Epub 2008 May 8. Review.

41.

Development of custom-built bone scaffolds using mesenchymal stem cells and apatite-wollastonite glass-ceramics.

Dyson JA, Genever PG, Dalgarno KW, Wood DJ.

Tissue Eng. 2007 Dec;13(12):2891-901.

PMID:
17764401
42.

Non-epithelial oral mucosal progenitor cell populations.

Stephens P, Genever P.

Oral Dis. 2007 Jan;13(1):1-10. Review.

PMID:
17241423
43.

MicroRNA regulation of osteogenic differentiation.

Genever P.

J Stem Cells Regen Med. 2007 May 16;2(1):54-5. eCollection 2007. No abstract available.

PMID:
24692903
44.

Current perspectives on NMDA-type glutamate signalling in bone.

Spencer GJ, McGrath CJ, Genever PG.

Int J Biochem Cell Biol. 2007;39(6):1089-104. Epub 2006 Nov 23. Review.

PMID:
17188550
45.

The effects of anticholinergic insecticides on human mesenchymal stem cells.

Hoogduijn MJ, Rakonczay Z, Genever PG.

Toxicol Sci. 2006 Dec;94(2):342-50. Epub 2006 Sep 7.

PMID:
16960032
46.

Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.

Spencer GJ, Utting JC, Etheridge SL, Arnett TR, Genever PG.

J Cell Sci. 2006 Apr 1;119(Pt 7):1283-96. Epub 2006 Mar 7.

47.

Comparative characterization of hair follicle dermal stem cells and bone marrow mesenchymal stem cells.

Hoogduijn MJ, Gorjup E, Genever PG.

Stem Cells Dev. 2006 Feb;15(1):49-60.

PMID:
16522162
48.

Glutamate receptors on human melanocytes regulate the expression of MiTF.

Hoogduijn MJ, Hitchcock IS, Smit NP, Gillbro JM, Schallreuter KU, Genever PG.

Pigment Cell Res. 2006 Feb;19(1):58-67.

PMID:
16420247
49.

Rapid isolation, expansion, and differentiation of osteoprogenitors from full-term umbilical cord blood.

Hutson EL, Boyer S, Genever PG.

Tissue Eng. 2005 Sep-Oct;11(9-10):1407-20.

PMID:
16259596
50.

Interaction between organophosphate compounds and cholinergic functions during development.

Aluigi MG, Angelini C, Falugi C, Fossa R, Genever P, Gallus L, Layer PG, Prestipino G, Rakonczay Z, Sgro M, Thielecke H, Trombino S.

Chem Biol Interact. 2005 Dec 15;157-158:305-16. Epub 2005 Oct 28.

PMID:
16257396

Supplemental Content

Loading ...
Support Center